Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
venlafaxine hydrochloride, Quantity: 84.9 mg (Equivalent: venlafaxine, Qty 75 mg)
GM Pharma International Pty Ltd
Venlafaxine hydrochloride
Capsule, modified release
Excipient Ingredients: iron oxide black; colloidal anhydrous silica; ethylcellulose; iron oxide red; magnesium stearate; microcrystalline cellulose; povidone; purified talc; titanium dioxide; Gelatin; copovidone; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; Shellac; ethanol absolute; ammonia
Oral
28 capsules
(S4) Prescription Only Medicine
VENLABIC XR is indicated for the treatment of: - Major depression, including prevention of relapse and recurrence where appropriate; - Generalised anxiety disorder; - Social anxiety disorder; Panic disorder, including prevention of relapse.
Visual Identification: Peach opaque cap/ peach opaque body, size '1' hard capsule with thick and thin radial circular bands on both the cap and body in red ink.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-05-17